EUCTR2011-002104-32-DE进行中(未招募)不适用
A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetes
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female aged 6–64 years (both inclusive) at the time of signing informed consent.
- •2. Type 1 diabetes mellitus (as diagnosed clinically) = 12 months.
- •3. Body mass index (BMI) for children and adolescents (male and female) between the 3rd and 97th BMI percentile and for adults = 28.0 kg/m^2.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 26
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 13
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening.
- •2. Smoker (defined as a subject who is smoking at least one cigarette, cigar or pipe daily).
- •3. Not able or willing to refrain from smoking and use of nicotine substitute products during the inpatient period.
研究者
相似试验
进行中(未招募)
不适用
The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaDiseases of the circulatory systemKCT0001258Hanlim Pharmaceutical40
已完成
不适用
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402KCT0003213avipharm38
进行中(未招募)
不适用
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 DiabetesType I diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2008-008306-43-DEovo Nordisk A/S
进行中(未招募)
不适用
A Trial Investigating the Pharmacokinetic Properties ofNN5401 in Children, Adolescents and Adults with Type1 DiabetesType 1 DiabetesEUCTR2009-016779-31-DEovo Nordisk A/S
招募中
不适用
Clinical trial to assess the pharmacokinetic characteristics of Lodivixx tab. 5/160mg in healthy male subjectsDiseases of the circulatory systemKCT0000710Hanlim Pharmaceutical60
